Care Beyond Diagnosis (CBD) has a vision for for improved patient-outcomes through both a small scale, patient specific approach and through large scale, internationally collaborated Rare Disorder guideline development programs.

Learn more about how we utilize industry leading virtual engagement software to coordinate consensus sessions among the worlds leading experts by reading here. https://www.within3.com/blog/vep-agency-spotlight-care-beyond-diagnosis

Special thanks to the Batten Disease News team and BioNews Services, LLC for their coverage of the CLN2 Guideline Development program and results. Read the story here:

Read the Story Here

Learn more about how G-I-N supports global guideline development and is working to establish and promote best-practices by clicking the logo below!

Care Beyond Diagnosis Feature Story

Follow the link to review our

Clinical Guidelines for CLN2 Disease.

Care Beyond Diagnosis (CBD) has a vision for for improved patient-outcomes through both a small scale, patient specific approach and through large scale, internationally collaborated Rare Disorder guideline development programs.

Special thanks to the Batten Disease News team and BioNews Services, LLC for their coverage of the CLN2 Guideline Development program and results. Read the story here:

Click link above!!